Evidence map›Paper›PMID 35903344›Full record

ArticleFrontiers in pharmacology2022

Assessment of the Potential of

Chao Li, Rou Wen, DeWen Liu, LiPing Yan, Qianfeng Gong, Huan Yu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Protective effect ofFrontiers in medicine · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chao LiSchool of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Rou WenSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
DeWen LiuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
LiPing YanSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
Qianfeng GongSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
Huan YuSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
Jiangxi University of Traditional Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNTianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric ulcer (GU) is one of the most commonly diagnosed diseases worldwide, threatening human health and seriously affecting quality of life. Reports have shown that the Chinese herbal medicine

Indexed as

gastric ulcergastroprotectionmetabolomicsnetwork pharmacologySarcandra glabra (thunb.) nakai

Identifiers

PMID35903344
PMCPMC9315220
OpenAlexW4285090947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.